- ISIN
- US8753722037
- CUSIP
- 875372203
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Nov 14, 2013
Highlights
- Market Cap
- $1.34B
- Enterprise Value
- $1.91B
- EPS (TTM)
- -$1.39
- Total Revenue (TTM)
- $1.03B
- Gross Profit (TTM)
- $564.40M
- EBITDA (TTM)
- -$75.59M
- Year Range
- $9.98 - $29.65
- Target Price
- $31.62
- ROA (TTM)
- -8.20%
- ROE (TTM)
- -71.41%
- Avg. Volume (1M)
- 2M
- Avg. Volume Value (1M)
- $27.81M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TNDM Performance Chart
Tandem Diabetes Care, Inc. (TNDM) is down 11.3% since the beginning of the year. At $20 per share, TNDM is trading 34.2% below its 52-week high of $30. Investors who bought $1,000 worth of TNDM shares 5 years ago would now be looking at an investment worth $179.
Loading charts...
Compare this symbol against anything
Returns By Period
Tandem Diabetes Care, Inc. (TNDM) has returned -11.28% so far this year and 26.62% over the past 12 months. Over the last ten years, TNDM has returned -10.99% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Tandem Diabetes Care, Inc.
- 1D
- 2.58%
- 1M
- 27.28%
- 6M
- -1.96%
- YTD
- -11.28%
- 1Y
- 26.62%
- 3Y*
- -15.44%
- 5Y*
- -29.08%
- 10Y*
- -10.99%
- ALL TIME*
- -16.57%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
TNDM Monthly Returns History
Based on dividend-adjusted daily data since Nov 14, 2013, TNDM's average daily return is +0.04%, while the average monthly return is +1.16%. At this rate, an investment would double in approximately 5.0 years.
Historically, 49% of months were positive and 51% were negative. The best month was May 2018 with a return of +83.9%, while the worst month was Oct 2017 at -66.2%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.
On a daily basis, TNDM closed higher 49% of trading days. The best single day was Aug 28, 2017 with a return of +44.3%, while the worst single day was Nov 2, 2016 at -58.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.51% | 27.20% | -24.23% | 1.85% | -11.91% | -12.27% | 29.22% | -11.28% | |||||
| 2025 | 2.89% | -40.26% | -13.46% | -12.06% | 17.63% | -5.95% | -16.42% | -19.70% | -2.96% | 15.32% | 50.07% | 4.62% | -38.98% |
| 2024 | -22.92% | 16.80% | 32.97% | 3.61% | 39.63% | -21.35% | -8.22% | 17.63% | -2.51% | -26.03% | -2.36% | 17.60% | 21.77% |
| 2023 | -9.37% | -11.98% | 13.25% | -2.54% | -34.34% | -5.58% | 42.30% | -21.65% | -24.09% | -16.71% | 16.99% | 46.15% | -34.19% |
| 2022 | -21.53% | -4.64% | 3.25% | -17.03% | -29.34% | -13.17% | 11.86% | -30.92% | 4.61% | 17.35% | -25.11% | 6.90% | -70.14% |
| 2021 | -3.17% | 3.60% | -8.06% | 4.14% | -7.08% | 14.06% | 11.57% | 3.22% | 6.43% | 14.20% | -5.73% | 17.12% | 57.32% |
Benchmark Metrics
Tandem Diabetes Care, Inc. has an annualized alpha of -4.64%, beta of 1.15, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since November 14, 2013.
- This stock participated in 160.88% of S&P 500 Index downside but only 32.11% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -4.64%
- Beta
- 1.15
- R²
- 0.07
- Upside Capture
- 32.11%
- Downside Capture
- 160.88%
Return for Risk
Risk / Return Rank
TNDM ranks 58 for risk / return — above 58% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Tandem Diabetes Care, Inc. (TNDM) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TNDM | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.10 | ||
| Sortino ratioReturn per unit of downside risk | -0.89 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.25 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.46 | 2.00 | -1.54 |
| Martin ratioReturn relative to average drawdown | 0.97 | 8.49 | -7.52 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Tandem Diabetes Care, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tandem Diabetes Care, Inc. was 99.25%, occurring on Nov 3, 2017. The portfolio has not yet recovered.
The current Tandem Diabetes Care, Inc. drawdown is 93.50%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.25%Nov 2017 | 3y 9mo | — | 12y 6moJan 2014 - now | — |
-8.83%Dec 2013 | 13d | 7d | 20dDec 2013 - Dec 2013 | — |
-8.24%Nov 2013 | 2d | 7d | 9dNov 2013 - Nov 2013 | — |
-1.92%Nov 2013 | 1d | 3d | 3dNov 2013 - Dec 2013 | — |
-1.23%Nov 2013 | 1d | 1d | 1dNov 2013 - Nov 2013 | — |
Drawdown Indicators
| TNDM | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.25% | -56.78% | -42.47% |
Max Drawdown (1Y)Largest decline over 1 year | -54.64% | -9.10% | -45.54% |
Max Drawdown (3Y)Largest decline over 3 years | -81.07% | -18.90% | -62.17% |
Max Drawdown (5Y)Largest decline over 5 years | -93.40% | -25.43% | -67.97% |
Max Drawdown (10Y)Largest decline over 10 years | -97.44% | -33.92% | -63.52% |
Current DrawdownCurrent decline from peak | -93.50% | -1.58% | -91.92% |
Average DrawdownAverage peak-to-trough decline | -77.37% | -10.70% | -66.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.18% | 2.14% | +24.04% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Tandem Diabetes Care, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Tandem Diabetes Care, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TNDM relative to other companies in the Medical Devices industry. Currently, TNDM has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TNDM in comparison with other companies in the Medical Devices industry. Currently, TNDM has a P/B value of 10.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TNDM
Add Tandem Diabetes Care, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TNDM